01
Innovation
Product development and the release of new features across our platforms.
Perspectives
Our priorities for the years ahead: innovate, grow the team, build strategic partnerships and engage with the scientific community.
Our goals
01
Product development and the release of new features across our platforms.
02
Recruiting new talent and expanding the team.
03
Finding and building new strategic partnerships.
04
Taking part in professional events to share our work and grow our network.
Clinical & regulatory path
Neurology and psychiatry first, then oncology (VESIPATH) and systemic diseases (VESIGEN).
Multi-centre clinical validation, with more than 300 patients planned across initial cohorts.
Targeting CE-IVD (EU) and the Swissmedic pathway, with a stepwise approach in the United States.
Centralised analysis services today; selective diagnostic kits and strategic partnerships next.
Researchers, clinicians, partners, talents and investors: we would be glad to hear from you.